Syneron Medical Ltd (ELOS) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
Syneron Medical Reports Revenue of $63.4 Million for the First Quarter 2015
May 13, 2015 6:16 AM EDTYOKNEAM, Israel, May 13, 2015 /PRNewswire/ --Â Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended March 31, 2015.
First Quarter 2015 and Recent Non-GAAP1 Highlights:
UltraShape launch-to-date U.S. installed base at more than 150 systems, including 31 systems sold in the first quarter and 25 more systems in the month of April. Generated $2.7 million in PicoWay sales and expanded FDA clearance to include the treatment of pigmented lesions. Introduced... More